Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development) - Image 1

£18.99

Humana Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Name: Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)
Brand: Humana
Price: 18.99 GBP
Availability: InStock

22900219

Oncology

It has never been this cheap. We have no record of a lower price.

£19 today · cheaper than every other day in the last 24 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 593 days • 593 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 593 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £19 (426 days, 71.8%)

Price range: £19 - £25

Price levels: 3 different prices over 593 days

Description

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response provides the most comprehensive body of knowledge available on the role of genetic and genomic variation in the individualization of drug therapies in cancer patients. As a consequence of the intrinsic chromosomal and genetic instability of the tumor genome, it is generally believed that tailoring of chemotherapy in cancer - tients might be achieved by molecular analysis of patient tumor DNA. In addition, to reduce the toxicity risk of patients, the tumor DNA information should be in- grated with the available data on polymorphic drug-metabolizing enzyme and tra- porter genes mediating the exposure of patients to active drugs and/or their active metabolites. The chapters of this book clearly show how DNA information from both the host (germline) and the tumor should be taken into account for rational selection of drug therapies in cancer patients, an aspect that received little attention, despite its importance. The availability of new molecular approaches to the selection of drug therapy is an emerging need, because the traditional approach based on the evaluation of patient and tumor characteristics is clearly far from optimal. Many treated patients do not experience signi?cant bene?ts from the treatment, while they often experience moderate to severe toxicities. In addition, the development and clinical use of novel molecularly targeted agents (alone or in combination with classical cytotoxic therapy) requires the und- standing of the molecular features of the tumors and the identi?cation of tumor markers of response.

Product Specifications

Brand: Humana
Model: 22900219
Format: Hardcover
ASIN: 1588296466
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 23 October 2008
Listed Since: 09 March 2007

Barcode

No barcode data available

Humana Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Target Discovery and Validation Reviews and Protocols: Emerging Strategies for Targets and Biomarker Discovery, Volume 1: 360 (Methods in Molecular Biology, 360)

Cancer Gene Therapy: Past Achievements And Future Challenges: 465 (Advances in Experimental Medicine and Biology, 465)

Cancer Gene Therapy: Past Achievements and Future Challenges: 465 (Advances in Experimental Medicine and Biology, 465)

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

Chemistry and Pharmacology of Anticancer Drugs

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Cancer: Principles and Practice of Oncology Primer of Molecular Biology in Cancer

Cancer Gene Profiling: Methods and Protocols: 1381 (Methods in Molecular Biology, 1381)

Principles of Cancer Genetics

Anticancer Genes: 818 (Advances in Experimental Medicine and Biology, 818)

MicroRNAs: Key Regulators of Oncogenesis

Cancer Genomics: Molecular Classification, Prognosis and Response Prediction

Molecular Biology of Human Cancers

Molecular Biology of Human Cancers

Cancer Epigenetics for Precision Medicine: Methods and Protocols: 1856 (Methods in Molecular Biology, 1856)

Principles of Cancer Genetics

Tumor Suppressor Genes in Human Cancer (Cancer Drug Discovery and Development)

Genetic Toxicology and Cancer Risk Assessment

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Targeted Therapies in Oncology

The Molecular Basis of Cancer

Anticancer Drug Discovery and Development: Natural Products and New Molecular Models: Proceedings of the Second Drug Discovery and Development ... 1991: 74 (Developments in Oncology, 74)

Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics

Cancer Genetics and Genomics for Personalized Medicine